Kyla Gelev is a recent graduate of the University of Southern California where she received her bachelor’s degree in Biology. Her interests revolve around personalized medicine and cancer genomics. She hopes to enter a graduate program focused on Bioinformatics, and in the future use computational skills to better understand the genome and identify and create individualized treatment options for cancer patients.
For the present year, Kyla is working at the Silva-Fisher Lab where her research involves late-stage relapse breast cancer and long noncoding RNAs. Late-stage relapse breast cancer occurs five years after initial treatment and is typically more aggressive and difficult to treat. She utilizes Locked Nucleic Acids to knockdown clinically significant long noncoding RNAs with the ultimate goal of determining why this reoccurrence occurs.